ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 17 filers reported holding ACORDA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,000 | +18.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | -8.3% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $12,000 | -7.7% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | 0.0% | 15,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $13,000 | +8.3% | 15,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $12,000 | -53.8% | 15,000 | -50.0% | 0.01% | -28.6% |
| Q3 2018 | $26,000 | +85.7% | 30,000 | +100.0% | 0.01% | -36.4% |
| Q2 2018 | $14,000 | 0.0% | 15,000 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $14,000 | +7.7% | 15,000 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $13,000 | -7.1% | 15,000 | 0.0% | 0.01% | -81.7% |
| Q3 2017 | $14,000 | +7.7% | 15,000 | 0.0% | 0.06% | – |
| Q2 2017 | $13,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |